Literature DB >> 30847799

Cancer-associated fibroblasts: how do they contribute to metastasis?

Mei Qi Kwa1, Kate M Herum1, Cord Brakebusch2.   

Abstract

Cancer-associated fibroblasts (CAFs) are activated fibroblasts in the tumor microenvironment. They are one of the most prominent cell types in the stroma and produce large amounts of extracellular matrix molecules, chemokines, cytokines and growth factors. Importantly, CAFs promote cancer progression and metastasis by multiple pathways. This, together with their genetic stability, makes them an interesting target for cancer therapy. However, CAF heterogeneity and limited knowledge about the function of the different CAF subpopulations in vivo, are currently major obstacles for identifying specific molecular targets that are of value for cancer treatment. In this review, we discuss recent major findings on CAF development and their metastasis-promoting functions, as well as open questions to be addressed in order to establish successful cancer therapies targeting CAFs.

Entities:  

Keywords:  Cancer associated fibroblasts; Desmoplasia; Metastasis; Premetastatic niche

Mesh:

Year:  2019        PMID: 30847799     DOI: 10.1007/s10585-019-09959-0

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  171 in total

Review 1.  Regulation of PDGF and its receptors in fibrotic diseases.

Authors:  James C Bonner
Journal:  Cytokine Growth Factor Rev       Date:  2004-08       Impact factor: 7.638

2.  Integrated analysis reveals critical genomic regions in prostate tumor microenvironment associated with clinicopathologic phenotypes.

Authors:  Shingo Ashida; Mohammed S Orloff; Gurkan Bebek; Li Zhang; Pan Zheng; Donna M Peehl; Charis Eng
Journal:  Clin Cancer Res       Date:  2012-01-24       Impact factor: 12.531

Review 3.  Ramucirumab in metastatic colorectal cancer: evidence to date and place in therapy.

Authors:  Helena Verdaguer; Josep Tabernero; Teresa Macarulla
Journal:  Ther Adv Med Oncol       Date:  2016-03-11       Impact factor: 8.168

4.  Macrophage-mediated transfer of cancer-derived components to stromal cells contributes to establishment of a pro-tumor microenvironment.

Authors:  Michinobu Umakoshi; So Takahashi; Go Itoh; Sei Kuriyama; Yuto Sasaki; Kazuyoshi Yanagihara; Masakazu Yashiro; Daichi Maeda; Akiteru Goto; Masamitsu Tanaka
Journal:  Oncogene       Date:  2018-11-20       Impact factor: 9.867

5.  Matrix crosslinking forces tumor progression by enhancing integrin signaling.

Authors:  Kandice R Levental; Hongmei Yu; Laura Kass; Johnathon N Lakins; Mikala Egeblad; Janine T Erler; Sheri F T Fong; Katalin Csiszar; Amato Giaccia; Wolfgang Weninger; Mitsuo Yamauchi; David L Gasser; Valerie M Weaver
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

6.  Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration.

Authors:  Valbona Luga; Liang Zhang; Alicia M Viloria-Petit; Abiodun A Ogunjimi; Mohammad R Inanlou; Elaine Chiu; Marguerite Buchanan; Abdel Nasser Hosein; Mark Basik; Jeffrey L Wrana
Journal:  Cell       Date:  2012-12-21       Impact factor: 41.582

7.  Tumor-associated fibroblasts predominantly come from local and not circulating precursors.

Authors:  Ainhoa Arina; Christian Idel; Elizabeth M Hyjek; Maria-Luisa Alegre; Ying Wang; Vytautas P Bindokas; Ralph R Weichselbaum; Hans Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-17       Impact factor: 11.205

8.  Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers.

Authors:  Roni Allaoui; Caroline Bergenfelz; Sofie Mohlin; Catharina Hagerling; Kiarash Salari; Zena Werb; Robin L Anderson; Stephen P Ethier; Karin Jirström; Sven Påhlman; Daniel Bexell; Balázs Tahin; Martin E Johansson; Christer Larsson; Karin Leandersson
Journal:  Nat Commun       Date:  2016-10-11       Impact factor: 14.919

9.  Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer.

Authors:  Elvira Donnarumma; Danilo Fiore; Martina Nappa; Giuseppina Roscigno; Assunta Adamo; Margherita Iaboni; Valentina Russo; Alessandra Affinito; Ilaria Puoti; Cristina Quintavalle; Anna Rienzo; Salvatore Piscuoglio; Renato Thomas; Gerolama Condorelli
Journal:  Oncotarget       Date:  2017-03-21

10.  TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.

Authors:  Sanjeev Mariathasan; Shannon J Turley; Dorothee Nickles; Alessandra Castiglioni; Kobe Yuen; Yulei Wang; Edward E Kadel; Hartmut Koeppen; Jillian L Astarita; Rafael Cubas; Suchit Jhunjhunwala; Romain Banchereau; Yagai Yang; Yinghui Guan; Cecile Chalouni; James Ziai; Yasin Şenbabaoğlu; Stephen Santoro; Daniel Sheinson; Jeffrey Hung; Jennifer M Giltnane; Andrew A Pierce; Kathryn Mesh; Steve Lianoglou; Johannes Riegler; Richard A D Carano; Pontus Eriksson; Mattias Höglund; Loan Somarriba; Daniel L Halligan; Michiel S van der Heijden; Yohann Loriot; Jonathan E Rosenberg; Lawrence Fong; Ira Mellman; Daniel S Chen; Marjorie Green; Christina Derleth; Gregg D Fine; Priti S Hegde; Richard Bourgon; Thomas Powles
Journal:  Nature       Date:  2018-02-14       Impact factor: 49.962

View more
  41 in total

1.  Pan-cancer analysis of osteogenesis imperfecta causing gene SERPINF1.

Authors:  Chao Zhang; Wei Yang; Shanshan Zhang; Yongtao Zhang; Pengchao Liu; Xianxian Li; Wei Zhi; Dan Yang; Mian Li; Yanqin Lu
Journal:  Intractable Rare Dis Res       Date:  2022-02

Review 2.  What Inhibits Natural Killers' Performance in Tumour.

Authors:  Ines Papak; Elżbieta Chruściel; Katarzyna Dziubek; Małgorzata Kurkowiak; Zuzanna Urban-Wójciuk; Tomasz Marjański; Witold Rzyman; Natalia Marek-Trzonkowska
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

3.  Metastatic Transition of Pancreatic Ductal Cell Adenocarcinoma Is Accompanied by the Emergence of Pro-Invasive Cancer-Associated Fibroblasts.

Authors:  Shaofei Liu; Yasir Suhail; Ashkan Novin; Lorrie Perpetua
Journal:  Cancers (Basel)       Date:  2022-04-28       Impact factor: 6.575

Review 4.  Phenotype plasticity as enabler of melanoma progression and therapy resistance.

Authors:  Imanol Arozarena; Claudia Wellbrock
Journal:  Nat Rev Cancer       Date:  2019-06-17       Impact factor: 60.716

Review 5.  Cancer-associated fibroblasts: overview, progress, challenges, and directions.

Authors:  Qinrong Ping; Ruping Yan; Xin Cheng; Wenju Wang; Yiming Zhong; Zongliu Hou; Yunqiang Shi; Chunhui Wang; Ruhong Li
Journal:  Cancer Gene Ther       Date:  2021-03-12       Impact factor: 5.987

Review 6.  Cancer Stem Cell Plasticity - A Deadly Deal.

Authors:  Archana P Thankamony; Kritika Saxena; Reshma Murali; Mohit Kumar Jolly; Radhika Nair
Journal:  Front Mol Biosci       Date:  2020-04-30

Review 7.  The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome.

Authors:  Elisa D'Arcangelo; Nila C Wu; Jose L Cadavid; Alison P McGuigan
Journal:  Br J Cancer       Date:  2020-01-29       Impact factor: 7.640

Review 8.  Tumor-Associated Fibroblast-Targeting Nanoparticles for Enhancing Solid Tumor Therapy: Progress and Challenges.

Authors:  Wenpan Li; Nicholas Little; Jonghan Park; Cole Alexander Foster; Jiawei Chen; Jianqin Lu
Journal:  Mol Pharm       Date:  2021-07-14       Impact factor: 4.939

Review 9.  Mitogen-Activated Protein Kinases (MAPKs) and Cholangiocarcinoma: The Missing Link.

Authors:  Chaobo Chen; Leonard J Nelson; Matías A Ávila; Francisco Javier Cubero
Journal:  Cells       Date:  2019-09-28       Impact factor: 6.600

Review 10.  Are Synapse-Like Structures a Possible Way for Crosstalk of Cancer with Its Microenvironment?

Authors:  Irina V Alekseenko; Igor P Chernov; Sergei V Kostrov; Eugene D Sverdlov
Journal:  Cancers (Basel)       Date:  2020-03-27       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.